Company Overview
Snapshot
Founded in August 2017 by Alex Kozak, Israel Shapiro, and Mark Safro, FortePhest operates with 1–10 employees. The company has raised $1.4 million across two funding rounds. In February 2022, FortePhest secured a Series B investment from BASF Venture Capital and Orbia Ventures to accelerate its development programs.
Business overview
FortePhest is a biotechnology startup focused on developing advanced solutions for crop protection. The company's core technology, H-Forte, is a novel herbicide designed to combat herbicide-resistant weeds and invasive plants. H-Forte leverages a recently discovered mechanism of action, inspired by natural plant protectors, to target a key enzyme in protein synthesis, phenylalanine tRNA synthetase, thereby disrupting protein structure in weeds. FortePhest serves the agriculture industry, operating within the Agriculture & Food Technologies sector with a focus on sustainable farming and agtech.
Strategic signal
In February 2022, FortePhest received a Series B investment from BASF Venture Capital and Orbia Ventures. This strategic investment signals strong validation of FortePhest's innovative biotechnology for combating herbicide-resistant weeds, a critical challenge in global agriculture. The funding is intended to accelerate development programs and facilitate partnerships for commercializing novel crop protection products, indicating a clear path towards market expansion and addressing sustainable food production needs.
Log in to access full profile ›Company Intelligence Q&A
- What is FortePhest's primary focus?
- FortePhest is a biotechnology startup dedicated to developing new technologies to combat herbicide-resistant weeds and invasive plants, aiming to enhance crop protection.
- When was FortePhest founded and by whom?
- FortePhest was founded in August 2017 by co-founders Alex Kozak, Israel Shapiro, and Mark Safro.
- What is H-Forte and how does it work?
- H-Forte is FortePhest's herbicide, which utilizes a recently discovered mechanism of action inspired by natural plant protectors. It targets phenylalanine tRNA synthetase, a key enzyme in protein synthesis, to disrupt protein structure and control resistant weeds.
- Which investors participated in FortePhest's Series B funding round?
- In February 2022, FortePhest secured a Series B investment from BASF Venture Capital and Orbia Ventures.
- What is the total capital raised by FortePhest?
- FortePhest has raised a total of $1.4 million across two funding rounds.